STAT1 binds to the herpes simplex virus type 1 latency-associated transcript promoter
Tóm tắt
The authors hypothesized that environmental stimuli induce cytokines that act through an intracellular cascade, which includes signal transducers and activators of transcription (STATs), to change herpes simplex virus (HSV) gene expression, thereby inducing viral reactivation. The HSV type 1 (HSV-1) latency-associated transcript (LAT) gene regulates viral reactivation within neurons via an unknown mechanism. HSV-1 deletion mutants that are missing key portions of the LAT gene, particularly the 3′ region of the LAT promoter, do not reactivate normally in vivo. The authors hypothesized that STAT transcription factors may bind in this region to regulate viral reactivation. Electrophoretic mobility shift assay (EMSA) experiments were performed by incubating mouse trigeminal ganglion (TG) nuclear extracts with each of three overlapping sequences representing the 3′ region of the HSV-1 LAT promoter (referred to as oligos L1, L2, and L3). The ganglionic nuclear extracts bound specifically to oligos L1 and L3, but not L2. Oligos L1 and L3 contain predicted STAT binding sequences whereas L2 does not. Specific binding to oligo L3 (including the TATA box sequence) was supershifted by incubating with anti-STAT1 antibodies, but not by incubating with anti-STAT3 or anti-STAT5a antibodies. Specific L3 binding was reduced by competing with excess unlabeled STAT1 consensus sequences. These results indicate that STAT1, probably as part of a complex, is capable of binding to the LAT promoter on or near the TATA box. Further studies are required to determine if STAT1 is required for LAT expression in vivo. This work supports the hypothesis that interferons act through STAT1 to regulate the expression of HSV-1 LAT.
Tài liệu tham khảo
Ackland-Berglund C, Davido D, Leib D (1995). The roles of cAMP-response element and TATA box expression of the HSV-1 LATs. Virology 210: 141–151.
Ahmed M, Lock M, Miller CG, Fraser NW (2002). Regions of the herpes simplex virus type 1 latency-associated transcript that protect cells from apoptosis in vitro and protect neuronal cells in vivo. J Virol 76: 717–729.
Akira S, Nishio Y, Tanaka T, Inoue M, Matsusaka T, Wang XJ, Wei S, Yoshida N, Kishimoto T (1995). Transcription factors NF-IL-6 and APRF are involved in gp130-mediated signaling pathway. Ann N Y Acad Sci 762: 15–28.
Block T, Hill J (1997). The latency associated transcripts (LAT) of herpes simplex virus: still no end in sight. J NeuroVirol 3: 313–321.
Bloom D, Devi-Rao G, Hill J, Stevens J, Wagner E (1994). Molecular analysis of HSV-1 during epinephrine induced reactivation of latently infected rabbits in vivo. J Virol 68: 1283–1292.
Cantin E, Tanamachi B, Openshaw H (1999). Role for gamma interferon in control of HSV-1 reactivation. J Virol 73: 3418–3423.
Chatterjee-Kishore M, VanDen Akker F, Stark J (2000). Association of STATs with relatives and friends. Trends Cell Biol 10: 106–111.
Chen X, Schmidt MC, Goins WF, Glorioso JC (1995). Two herpes simplex virus type 1 latency-active promoters differ in their contributions to latency-associated transcript expression during lytic and latent infections. J Virol 69: 7899–7908.
Dawson C (1995). Management of herpes simplex eye diseases. In: Clinical management of herpes viruses, Vol. 1. Sacks SL, Strauss SE, Whitley RJ, Griffiths PD (eds). Amsterdam: IOS Press, pp 127–136.
Dobson A, Margolis T, Gomes W, Feldman L (1995). In vivo deletion analysis of the HSV-1 LAT promoter. J Virol 69: 2264–2270.
Drolet BS, Perng GC, Slanina SM, Yukht A, Nesburn AB, Wechsler SL (1998). The region of HSV-1 LAT gene involved in spontaneous reactivation does not encode a functional protein. Virology 242: 221–232.
Fraser NW, Block TM, Spivack JG (1992). The latency-associated transcripts of HSV: RNA in search of function. Virology 191: 1–8.
Halford WP, Gebhardt BM, Carr DJ (1996). Mechanisms of herpes simplex virus type 1 reactivation. J Virol 70: 5051–5060.
Henderson G, Peng W, Jin L, Perng G, Nesburn A, Wechsler S, Jones C (2002). Regulation of caspase 8 and caspase 9-induced apoptosis by the HSV-1 LAT. J NeuroVirol 8 (suppl 2): 103–111.
Hendricks RL, Tumpey TM, Finnegan A (1992). IFN-gamma and IL-2 are protective in the skin but pathologic in the corneas of HSV-1-infected mice. J Immunol 149: 3023–3028.
Hendricks RL, Weber PC, Taylor JL, Koumbis A, Tumpey TM, Glorioso JC (1991). Endogenously produced interferon alpha protects mice from herpes simplex virus type 1 corneal disease. J Gen Virol 72: 1601–1610.
Hill JM, Sedarati F, Javier RT, Wagner EK, Stevens JG (1990). Herpes simplex virus latent phase transcription facilitates in vivo reactivation. Virology 174: 117–125.
Kriesel J, Jones B, Hwang I, Dahms K, Spruance S (2001). Signal transducers and activators of transcription (STATs) are detectable in mouse trigeminal ganglion neurons. J Interferon Cytokine Res 21: 445–450.
Kriesel J, Ricigliano J, Spruance S, Garza H, Hill J (1998). Neuronal reactivation of herpes simplex virus may involve interleukin-6. J NeuroVirol 3: 441–448.
Kriesel JD, Araneo BA, Petajan JP, Spruance SL, Stromatt S (1994). Herpes labialis associated with recombinant human ciliary neurotrophic factor. J Infect Dis 170: 1046.
Kriesel JD, Gebhardt BM, Hill JM, Maulden SA, Hwang IP, Clinch TE, Cao X, Spruance SL, Araneo BA (1997). Anti-Interleukin-6 antibodies inhibit herpes simplex virus reactivation. J Infect Dis 175: 821–827.
Laycock KA, Lee SF, Brady RH, Pepsose JS (1991). Characterization of a murine model of recurrent HSV keratitis induced by ultraviolet B radiation. Invest Ophthamol Vis Sci 32: 2741–2746.
Mador N, Goldenberg D, Cohen O, Panet A, Steiner I (1998). HSV-1 LAT’s suppress viral replication and reduce immediate-early gene mRNA levels in a neuronal cell line. J Virol 72: 5067–5075.
McGeouch DJ, Dalrymple MA, Davison AJ, Dolan A, Frame MC, McNab D, Perry LJ, Scott JE, Taylor P (1988). The complete DNA sequence of the long unique region in the genome of HSV-1. J Gen Virol 69: 1531.
McKenzie RC, Sauder DN (1994). Ultraviolet radiation: effects on the immune system. Ann RCPSC 27: 20–26.
Perng G, Jones C, Ciacci-Zanella J, Stone M, Henderson G, Yukht A, Slanina S, Hofman F, Ghiasi H, Nesburn A, Wechsler S (2000a). Virus-induced neuronal apoptosis blocked by HSV LAT. Science 287: 1500–1503.
Perng G, Slanina S, Nesburn A, Wechsler S (1996). The spontaneous reactivation function of the HSV-1 LAT gene resides completely within the first 1.5 kilobases of the 8.3 kilobase primary transcript. J Virol 70: 976–984.
Perng G, Slanina S, Yukht A, Ghiasi H, Nesburn A, Wechsler S (2000b). The LAT gene enhances establishment of HSV-1 latency in rabbits. J Virol 74: 1885–1891.
Perng GC, Dunkel EC, Geary PA, Slanina SM, Ghiasi H, Kaiwar R, Nesburn AB, Wechsler SL (1994). The latency-associated transcript gene of herpes simplex virus type 1 (HSV-1) is required for efficient in vivo spontaneous reactivation of HSV-1 from latency. J Virol 68: 8045–8055.
Perng GC, Maguen B, Jin L, Mott KR, Osorio N, Slanina SM, Yukht A, Ghiasi H, Nesburn AB, Inman M, Henderson G, Jones C, Wechsler SL (2002). A gene capable of blocking apoptosis can substitute for the herpes simplex virus type 1 latency-associated transcript gene and restore wild-type reactivation levels. J Virol 76: 1224–1235.
Rajan P, Gearan T, Fink J (1998). LIF and NGF regulate STAT activation in sympathetic ganglia: convergence of cytokine- and neurotrophin-signaling pathways. Brain Res 802: 198–204.
Sawtell NM (1998). The probability of in vivo reactivation of herpes simplex virus type 1 increases with the number of latently infected neurons in the ganglia. J Virol 72: 6888–6892.
Sawtell NM, Poon DK, Tansky CS, Thompson RL (1998). The latent herpes simplex virus type 1 genome copy number in individual neurons is virus strain specific and correlates with reactivation. J Virol 72: 5343–5350.
Schindler C, Darnell J (1995). Transcriptional responses to polypeptide ligands: the JAK-STAT pathway. Annu Rev Biochem 64: 621–651.
Spruance SL (1995). Herpes simplex labialis. In: Clinical management of herpes viruses, Vol. 1. Sacks SL, Strauss SE, Whitley RJ, Griffiths PD (eds). Amsterdam: IOS Press, pp 3–42.
Stevens JG (1990). Transcripts associated with herpes simplex virus latency. Adv Exp Med Biol 278: 199–204.
Thomas S, Gough G, Latchman D, Coffin R (1999). HSV LAT encodes a protein which greatly enhances virus growth, can compensate for deficiencies in IE gene expression, and is likely to function during reactivation from viral latency. J Virol 73: 6618–6625.
Thomas S, Lilley C, Latchman D, Coffin R (2002). A protein encoded by the HSV-1 2 kb LAT transcript is phosphorylated, localized to the nucleus, and overcomes the repression of expression from exogenous promoters when inserted in the quiescent HSV genome. J Virol 76: 4056–4067.
Zwaagstra JC, Ghiasi H, Nesburn AB, Wechsler SL (1991). Identification of a major regulatory sequence in the LAT promoter of HSV-1. Virology 182: 287–297.